Back to User profile » Dr Meng Wang

Papers published by Dr Meng Wang:


Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer

Lyu L, Wang M, Zheng Y, Tian T, Deng Y, Xu P, Lin S, Yang S, Zhou L, Hao Q, Wu Y, Dai Z, Kang H

Cancer Management and Research 2020, 12:12457-12471

Published Date: 3 December 2020

Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer

Xu P, Yao J, Li Z, Wang M, Zhou L, Zhong G, Zheng Y, Li N, Zhai Z, Yang S, Wu Y, Zhang D, Dai Z

International Journal of Nanomedicine 2020, 15:2659-2668

Published Date: 21 April 2020

Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study

Yao L, Zhou L, Deng Y, Zheng Y, Yang P, Wang M, Dong S, Hao Q, Xu P, Li N, Wu Y, Zhai Z, Lyu L, Dai Z

OncoTargets and Therapy 2019, 12:8241-8247

Published Date: 7 October 2019

Prognostic values of HE4 expression in patients with cancer: a meta-analysis

Dai C, Zheng Y, Li Y, Tian T, Wang M, Xu P, Deng Y, Hao Q, Wu Y, Zhai Z, Dai Z, Lyu J

Cancer Management and Research 2018, 10:4491-4500

Published Date: 10 October 2018

Pooling analysis on prognostic value of PHH3 expression in cancer patients

Hao Q, Dai C, Deng Y, Xu P, Tian T, Lin S, Wang M, Liu K, Song D, Wu Y, Guo Y, Dai Z

Cancer Management and Research 2018, 10:2279-2288

Published Date: 30 July 2018

CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study

Yang P, Wang M, Tian T, Feng Y, Zheng Y, Yang T, Li H, Lin S, Xu P, Deng Y, Hao Q, Li N, Guan F, Dai Z

Cancer Management and Research 2018, 10:1791-1798

Published Date: 3 July 2018

Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women

Tian T, Wang M, Zheng Y, Yang T, Zhu W, Li H, Lin S, Liu K, Xu P, Deng Y, Zhou L, Dai Z

Cancer Management and Research 2018, 10:867-872

Published Date: 26 April 2018

Association between body mass index and breast cancer risk: evidence based on a dose–response meta-analysis

Liu K, Zhang W, Dai Z, Wang M, Tian T, Liu X, Kang H, Guan H, Zhang S, Dai Z

Cancer Management and Research 2018, 10:143-151

Published Date: 18 January 2018

Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas

Xu P, Zhao Y, Liu K, Lin S, Liu X, Wang M, Yang P, Tian T, Zhu Y, Dai Z

Cancer Management and Research 2017, 9:821-837

Published Date: 12 December 2017

Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis

Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z

OncoTargets and Therapy 2017, 10:3625-3634

Published Date: 21 July 2017

Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women

Wang M, Wang Z, Wang XJ, Jin TB, Dai ZM, Kang HF, Guan HT, Ma XB, Liu XH, Dai ZJ

Drug Design, Development and Therapy 2016, 10:2359-2367

Published Date: 25 July 2016

PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk

Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ

Therapeutics and Clinical Risk Management 2015, 11:237-245

Published Date: 13 February 2015

Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls

Gao J, Kang AJ, Lin S, Dai ZJ, Zhang SQ, Liu D, Zhao Y, Yang PT, Wang M, Wang XJ

Therapeutics and Clinical Risk Management 2014, 10:269-277

Published Date: 15 April 2014